Link Medicine secures $40M for Alzheimer's drug trial

09/30/2008 | Boston Globe (tiered subscription model), The

Link Medicine has raised an additional $40 million in venture capital to finance clinical trials of its drug candidate for Alzheimer's and Parkinson's. Despite problems in the U.S. financial markets, venture capitalists continue to show interest in companies that focus on "novel science in areas of high unmet need," Link CEO Adam Rosenberg said.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations